Shawn H. R. Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shawn H. R. Lee has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Jun J. Yang
Department of Pharmacy and Pharmaceutical Sciences St. Jude Children's Research Hospital Memphis Tennessee USA
25 shared publications - Amira Elhachimi
Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
23 shared publications - Andrew D. Hughes
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
23 shared publications - Anna Eames Seffernick
14Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, Tennessee
23 shared publications - Brent L. Wood
Childrens Hospital Los Angeles, Los Angeles, California, United States
23 shared publications - Caroline Diorio
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
23 shared publications
Latest Publications
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S11 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Supplementary Figure S1. T-ALL subtype classifying driver genes among individuals of European, Admixed American, and African ancestry. Supplementary Figure S2. T-ALL subtype classifying driver genes among patients with Early T-cell Precursor (ETP)-like subtype among individuals of European, Admixed American and African ancestry. Supplementary Figure S3. Distribution of 15 genomically defined T-ALL subtypes described by Pölönen and colleagues (16) among individuals of African and Non-African ancestry. Supplementary Figure S4. 5-year event free survival for NOTCH1 and FBXW7 by ancestral group. Supplementary Figure S5. Prevalence of (A) coding versus non-coding alterations and (B) types of pathogenic variants in NOTCH1 among individuals of African versus non-African ancestry. Supplementary Figure S6. Event free survival among all patients, patients of European, Admixed American, and African ancestry by NOTCH1 alterations (no mutation, favorable, unfavorable). Supplementary Figure S7. NOTCH1 coding mutation types (frameshift, missense, nonsense) on a lollipop plot in patients of European, African, and Admixed American Ancestry. Supplementary Figure S8. 5-year event free survival for genes with at least 5% frequency for each ancestral group (CDKN2A, PHF6, PTEN, DNM2). Supplementary Figure S9. 5-year event free survival for genes with at least 5% frequency for each ancestral group (LEF1, MYB, MYC, 6q loss). Supplementary Figure S10. 5-year event free survival for genes with at least 5% frequency for each ancestral group (WT1, USP7, IL7R, N/KRAS). Supplementary Figure S11. Distribution of genetic ancestral composition of individuals by categorically defined genetic ancestry.
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S11 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Supplementary Figure S1. T-ALL subtype classifying driver genes among individuals of European, Admixed American, and African ancestry. Supplementary Figure S2. T-ALL subtype classifying driver genes among patients with Early T-cell Precursor (ETP)-like subtype among individuals of European, Admixed American and African ancestry. Supplementary Figure S3. Distribution of 15 genomically defined T-ALL subtypes described by Pölönen and colleagues (16) among individuals of African and Non-African ancestry. Supplementary Figure S4. 5-year event free survival for NOTCH1 and FBXW7 by ancestral group. Supplementary Figure S5. Prevalence of (A) coding versus non-coding alterations and (B) types of pathogenic variants in NOTCH1 among individuals of African versus non-African ancestry. Supplementary Figure S6. Event free survival among all patients, patients of European, Admixed American, and African ancestry by NOTCH1 alterations (no mutation, favorable, unfavorable). Supplementary Figure S7. NOTCH1 coding mutation types (frameshift, missense, nonsense) on a lollipop plot in patients of European, African, and Admixed American Ancestry. Supplementary Figure S8. 5-year event free survival for genes with at least 5% frequency for each ancestral group (CDKN2A, PHF6, PTEN, DNM2). Supplementary Figure S9. 5-year event free survival for genes with at least 5% frequency for each ancestral group (LEF1, MYB, MYC, 6q loss). Supplementary Figure S10. 5-year event free survival for genes with at least 5% frequency for each ancestral group (WT1, USP7, IL7R, N/KRAS). Supplementary Figure S11. Distribution of genetic ancestral composition of individuals by categorically defined genetic ancestry.
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
T-cell Acute Lymphoblastic Leukemia subtype by Categorical Genetic Ancestry
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
T-cell Acute Lymphoblastic Leukemia subtype by Categorical Genetic Ancestry
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Table S6 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Association of Genetic Ancestry (25% interval) as Continuous Variables with Survival Outcomes.
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Association of Genetic Ancestry (25% interval) as Continuous Variables with Survival Outcomes.
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
T-cell Acute Lymphoblastic Leukemia Genomic Subtype Description.
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
T-cell Acute Lymphoblastic Leukemia Genomic Subtype Description.
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Association of Genetic Ancestries (25% Interval) as Continuous Variables with Biologic Subtype (TAL1 DP-like as reference subtype) Using Multinomial Regression Model.
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Association of Genetic Ancestries (25% Interval) as Continuous Variables with Biologic Subtype (TAL1 DP-like as reference subtype) Using Multinomial Regression Model.
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Table S8 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Frequency of Genetic Alterations of Genes in the NOTCH Pathway by Ancestry.
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Frequency of Genetic Alterations of Genes in the NOTCH Pathway by Ancestry.
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Table S7 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Types of Reported Events by Genetic Ancestry.
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S7 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Types of Reported Events by Genetic Ancestry.
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Table S10 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Table S10 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S10 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Table S10 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Table S9 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Association of NOTCH pathway alteration with Survival Outcomes stratified by categorical genetic ancestry.
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S9 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Association of NOTCH pathway alteration with Survival Outcomes stratified by categorical genetic ancestry.
- Open Access
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
T-cell Acute Lymphoblastic Leukemia Pathway Alterations by Categorical Genetic Ancestry
- 7 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
T-cell Acute Lymphoblastic Leukemia Pathway Alterations by Categorical Genetic Ancestry